|
2016 Journal Article The authors replyChen, Andrew C., Martin, Andrew J. and Damian, Diona L. (2016). The authors reply. New England Journal of Medicine, 374 (8). doi: 10.1056/NEJMc1514791 |
|
2016 Journal Article Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinomaHong, Angela, Zhang, Xiaoying, Jones, Deanna, Veillard, Anne-Sophie, Zhang, Mei, Martin, Andrew, Lyons, J. Guy, Lee, C. Soon and Rose, Barbara (2016). Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma. Radiotherapy and Oncology, 118 (2), 342-349. doi: 10.1016/j.radonc.2016.02.009 |
|
2016 Journal Article Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniquesDuchesne, Gillian M., Haworth, Annette, Bone, Eric, Carter, Hannah, Ebert, Martin A., Gagliardi, Frank, Gibbs, Adrian, Hornby, Colin, Martin, Andrew, Sidhom, Mark, Wood, Maree and Jackson, Michael (2016). Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology, 60 (1), 129-137. doi: 10.1111/1754-9485.12390 |
|
2016 Journal Article A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipientsChen, A. C., Martin, A. J., Dalziell, R. A., McKenzie, C. A., Lowe, P. M., Eris, J. M., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Bielski, V. A., Halliday, G. M. and Damian, D. L. (2016). A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. British Journal of Dermatology, 175 (5), 1073-1075. doi: 10.1111/bjd.14662 |
|
2016 Journal Article Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: A longitudinal cohort studyKennedy, N. J., Peek, M. J., Quinton, A. E., Lanzarone, V., Martin, A., Benzie, R. and Nanan, R. (2016). Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: A longitudinal cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 123 (2), 225-232. doi: 10.1111/1471-0528.13758 |
|
2015 Journal Article BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301)Hayne, Dickon, Stockler, Martin, McCombie, Steve P., Chalasani, Venu, Long, Anne, Martin, Andrew, Sengupta, Shomik and Davis, Ian D. (2015). BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301). BMC Cancer, 15 (1) 432. doi: 10.1186/s12885-015-1431-6 |
|
2015 Conference Publication RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501Grummet, Jeremy, Davis, Ian, Martin, Andrew, Buchan, Nicholas, Chalasani, Venu, Frydenberg, Mark, Hayne, Dickon, Lalak, Andre, Patel, Manish, Williams, Andrew, Woo, Henry, Lawrence, Nicola, Chan, Howard, Bishop, Claudia, Wong, Nicole, Coskinas, Xanthi and Stockler, Martin (2015). RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303)Williams, Scott G., Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Long, Anne, Yip, Sonia, Tu, Emily, Chan, Howard, Lawrence, Nicky, McDermott, Ray, Hughes, Simon, Marchesin, Vittorio, Deignan, Olwyn and Nguyen, Paul L. (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303). HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304)Davis, Ian, Stockler, Martin, Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Dazo, Carlo, Long, Anne, Lawrence, Nicky, Chan, Howard, McDermott, Ray, Chowdhury, Simon, Marchesin, Vittorio, Deignan, Olwyn, Parulekar, Wendy, Suris, Alexander Montenegro and Sweeney, Christopher (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304). HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301)Chalasani, Venu, Sengupta, Shomik, Stockler, Martin, McCombie, Steve, Hawks, Cynthia, Krieger, Laurence, Anderson, Paul, Grummet, Jeremy, Mitterdorfer, Andrew J., Bishop, Conrad, Beardsley, Emma, Martin, Andrew, Lawrence, Nicola, Wong, Nicole, Chan, Howard, Pysarenko, Mariya, Harper, Matthew, Patel, Manish, Hamid, Akil, Davis, Ian and Hayne, Dickon (2015). RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301). HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERSMartin, Andrew (2015). ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERS. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Journal Article Benefit of treatment of latent tuberculosis infection in individual patientsDobler, Claudia C., Martin, Andrew and Marks, Guy B. (2015). Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal, 46 (5), 1397-1406. doi: 10.1183/13993003.00577-2015 |
|
2015 Journal Article A phase 3 randomized trial of nicotinamide for skin-cancer chemopreventionChen, Andrew C., Martin, Andrew J., Choy, Bonita, Fernandez-Penas, Pablo, Dalziell, Robyn A., McKenzie, Catriona A., Scolyer, Richard A., Dhillon, Haryana M., Vardy, Janette L., Kricker, Anne, George, Gayathri St., Chinniah, Niranthari, Halliday, Gary M. and Damian, Diona L. (2015). A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 373 (17), 1618-1626. doi: 10.1056/NEJMoa1506197 |
|
2015 Conference Publication Discussing and prescribing expensive unfunded anticancer drugs in AustraliaKarikios, D., Mileshkin, L., Martin, A., Ferraro, D. and Stockler, M. (2015). Discussing and prescribing expensive unfunded anticancer drugs in Australia. European Cancer Congress, Vienna Austria, 2015. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(16)30506-8 |
|
2015 Journal Article Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) FrameworkDuchesne, Gillian M., Grand, Mel, Kron, Tomas, Haworth, Annette, Corry, June, Jackson, Michael, Ng, Michael, Besuijen, Deidre, Carter, Hannah E., Martin, Andrew, Schofield, Deborah, Gebski, Val, Torony, Joan, Kovacev, Olga, Amin, Rowena and Burmeister, Bryan (2015). Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. Journal of Medical Imaging and Radiation Oncology, 59 (3), 363-370. doi: 10.1111/1754-9485.12255 |
|
2015 Journal Article EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaDavis, Ian D., Long, A., Yip, S., Espinoza, D., Thompson, J. F., Kichenadasse, G., Harrison, M., Lowenthal, R. M., Pavlakis, N., Azad, A., Kannourakis, G., Steer, C., Goldstein, D., Shapiro, J., Harvie, R., Jovanovic, L., Hudson, A. L., Nelson, C. C., Stockler, M. R. and Martin, A. (2015). EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. Annals of Oncology, 26 (6), 1118-1123. doi: 10.1093/annonc/mdv078 |
|
2015 Conference Publication A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2015 Journal Article Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancerMurray, Sonya R., Murchie, Peter, Campbell, Neil, Walter, Fiona M., Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Martin, Andrew, Goodall, Stephen, Barnes, David J. and Emery, Jon D (2015). Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer. BMJ Open, 5 (5) e008046, 1-7. doi: 10.1136/bmjopen-2015-008046 |
|
2014 Conference Publication THE PROCARE TRIAL: A PHASE II RANDOMISED CONTROLLED TRIAL OF SHARED CARE FOR FOLLOW-UP OF MEN WITH PROSTATE CANCEREmery, Jon, Schofield, Penny, Jefford, Michael, King, Madeleine, Pirotta, Marie, Hayne, Dickon, Martin, Andrew, Trevena, Lyndal, Lim, Tee and Constable, Roger (2014). THE PROCARE TRIAL: A PHASE II RANDOMISED CONTROLLED TRIAL OF SHARED CARE FOR FOLLOW-UP OF MEN WITH PROSTATE CANCER. HOBOKEN: WILEY-BLACKWELL. |
|
2014 Journal Article Physical activity and fitness in women with metastatic breast cancerYee, Jasmine, Davis, Glen M., Beith, Jane M., Wilcken, Nicholas, Currow, David, Emery, Jon, Phillips, Jane, Martin, Andrew, Hui, Rina, Harrison, Michelle, Segelov, Eva and Kilbreath, Sharon L. (2014). Physical activity and fitness in women with metastatic breast cancer. Journal of Cancer Survivorship, 8 (4), 647-656. doi: 10.1007/s11764-014-0378-y |
